Fred Hayden, MD


Dr. Hayden is Stuart S. Richardson Professor Emeritus of Clinical Virology and Professor Emeritus of Medicine at the University of Virginia School of Medicine in Charlottesville, Virginia, USA. He received his medical degree from Stanford University School of Medicine in 1973 and completed his clinical training in internal medicine and infectious diseases at Strong Memorial Hospital, University of Rochester, New York.  Dr Hayden joined the faculty of the University of Virginia in 1978, became Richardson Professor in 1990, and transitioned to emeritus status in 2015. During 2006-2008 he served as a medical officer in the Global Influenza Programme at the World Health Organization, Geneva and during 2008-2012 as influenza research coordinator at the Wellcome Trust, London.

His principle research interests have been on respiratory viral infections with a particular focus on the development and application of antiviral agents for influenza, rhinovirus, and coronavirus infections. He has contributed to the development of seven influenza antivirals approved for clinical use in one or more countries. During the COVID-19 pandemic he collaborated with colleagues in China to conduct the first controlled trials of candidate antivirals in hospitalized patients in Wuhan and has served as a consultant to platform trials (UK CTAP-RECOVERY, ACTIV), academic groups, and industry regarding the selection of therapeutics for clinical trials.  He has published over 450 peer-reviewed papers, chapters, and other articles, and co-edits the textbook Clinical Virology. In 2019, Dr Hayden received the Lifetime Achievement Award for Influenza Research from International Society for Influenza and Other Respiratory Viral Diseases.

More team members

Andrew Fradkin, JD
General Counsel
Walter Greenblatt, MBA
Chief Financial Officer
Mike McGinnis, MS, MBA
Head of Government Relations
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Chairwoman of the Board
Joan Fusco, PhD
Chief Development Officer
Tom Monath, MD
Chief Medical Officer
Sean Whelan, PhD
Allen Duplantier, PhD
Principal investigator
Daniel Graifman, MBA